Lexaria Bioscience Stock Forecast for 2023 - 2025 - 2030

Updated on 04/30/2024

Stock Rating
0
Price Target
$10.00
Consensus
Outperform
Upside
306.50%
Analysts
1
Stock Rating
0
Upside
306.50%
Analysts
1
Price Target
$10.00

Lexaria Bioscience Stock Forecast and Price Target

The average target price set lately by experts for Lexaria Bioscience to reach by the end of the year is $10.00, which would imply a potential upside of approximately 306.5 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $12.00 and a low estimate of $8.00.

$10.00

306.50% Upside

Outperform
Outperform

Lexaria Bioscience Fair Value Forecast for 2023 - 2025 - 2030

Lexaria Bioscience's Price has grown In the last three years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $0.00 – an increase of 100.00%. For the next six years, experts predict that Lexaria Bioscience's Fair Value will grow at a rate of 100.00%.

2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00

Lexaria Bioscience Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Lexaria Bioscience's Revenue has decreased from $310.00k to $230.00k – a 25.81% drop. In the next year, analysts believe that Revenue will reach $331.98k – an increase of 44.34%. For the next seven years, experts predict that Lexaria Bioscience's Revenue will grow at a rate of 79.94%.

2024 Rev Forecast
$331.98k
2025 Rev Forecast
$508.20k
2026 Rev Forecast
$419.52k
2027 Rev Forecast
$357.64k
2028 Rev Forecast
$362.13k
2029 Rev Forecast
$407.04k
2030 Rev Forecast
$413.86k

Lexaria Bioscience Dividend per Share Forecast for 2023 - 2025 - 2030

Lexaria Bioscience Free Cash Flow Forecast for 2023 - 2025 - 2030

Lexaria Bioscience EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Lexaria Bioscience's EBITDA has grown, moving from $-4.04M to $-6.39M – an increase of 58.17%. In the following year, the 0 analysts surveyed believe that Lexaria Bioscience's EBITDA will decrease by 13.33%, reaching $-5.54M. According to professionals, by 2030, Lexaria Bioscience's EBITDA will have decreased by 8.73%, falling down to $-5.83M.

2024 EBITDA Forecast
$-5538213.00
2025 EBITDA Forecast
$-5593410.52
2026 EBITDA Forecast
$-5899556.53
2027 EBITDA Forecast
$-6080476.26
2028 EBITDA Forecast
$-5894819.05
2029 EBITDA Forecast
$-5796179.08
2030 EBITDA Forecast
$-5832308.59

Lexaria Bioscience EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Lexaria Bioscience's EBIT has seen an increase, rising from $-4.15M to $-6.53M. This represents a growth of 57.35%. The next year, 0 experts forecast that Lexaria Bioscience's EBIT will decrease by 13.25%, reaching $-5.66M. In 2030, professionals predict that Lexaria Bioscience's EBIT will decrease by 8.83%, reaching $-5.95M.

2024 EBIT Forecast
$-5664992.67
2025 EBIT Forecast
$-5714089.27
2026 EBIT Forecast
$-6014840.84
2027 EBIT Forecast
$-6203506.34
2028 EBIT Forecast
$-6019468.99
2029 EBIT Forecast
$-5919545.80
2030 EBIT Forecast
$-5953287.21

Lexaria Bioscience EPS Price Prediction Forecast for 2023 - 2025 - 2030

Lexaria Bioscience's EPS has grown In the last three years, rising from $-1.26 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $0.00 – an increase of 100.00%. For the next six years, experts predict that Lexaria Bioscience's EPS will grow at a rate of 100.00%.

2025 EPS Forecast
$0.00
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00